Applications
Medical
Cardiovascular Health
ReOxy® is the only evidence-based medical device that improves exercise capacity and cardiovascular health in patients with coronary artery disease (CAD). It improve functional capacity when traditional exercice alone might be insufficient or risky.
EU Commission evaluation highly ranked ReOxy® project as a game changer in cardiac rehabilitation (HORIZON 2020 Programme).
A 5-week ReOxy®-based IHHT® program was found to be as effective as an 8-week exercise-based rehabilitation program in improving VO2 peak in older cardiac patients who were unable to perform regular exercise (Source)
| Clinical trials results | Patients benefits | Reference |
|---|---|---|
| Increases 6min walking test distance | Greater walking ability and endurance with less fatigue during physical activity | Source [6] |
| Increases aerobic capacity (VO2 peak) | Better cardiovascular fitness, improved endurance, similar effectiveness as traditional exercise rehab | Source [7] |
| Reduces systolic and diastolic blood pressure | Lower risk of heart attack and stroke, improved heart health | Source [9] |
| Enhances exercise tolerance and reduces angina symptoms | Greater ability to perform daily activities with less exertion | Source [8] |
Respiratory health
ReOxy® therapy has as shown benefits in long-COVID patients in a pilot clinical trial
| Clinical results | Patients benefits |
|---|---|
| Increased 6-minute walking test distance (+91.7m in IHHT group vs. +32.6m in control) | Better mobility and endurance, improved functional recovery |
| Improved stair climbing power (3.7-fold improvement vs. control) | Greater ability to perform daily activities with less exertion |
| Reduced dyspnea (Borg scale improvement 2x greater than control) | Greater ability to perform daily activities with less exertion |
Cognitive function
ReOxy® therapy has been clinically shown to enhance cognitive performance in elderly patients, supporting improved memory, attention, and executive function.
Key findings from a randomized controlled study (ages 64–92):
- +16.7% improvement in DemTect scores
→ Indicating a significant enhancement in global cognitive performance. - +10.7% improvement in Clock Drawing Test scores
→ Reflecting gains in visual-spatial processing, memory, attention, and executive functioning (core domains of daily cognitive competence). - Increased 6-minute walk test distance and reduced perceived pain
→ Improvements in physical capacity and pain management, both associated with better cognitive outcomes.
ReOxy is a non-invasive, well-tolerated intervention that can be seamlessly integrated into multimodal rehabilitation programs.
ReOxy® is the only device of it’s kind
with clinically proven benefits.
Reach out to us or discover more.